Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-24T02:16:06.136Z Has data issue: false hasContentIssue false

7 - Treatment of blepharospasm

Published online by Cambridge University Press:  28 July 2009

Daniel Truong
Affiliation:
Orange Coast Memorial Medical Center
Dirk Dressler
Affiliation:
Hannover Medical School, Hannover, Germany
Mark Hallett
Affiliation:
George Washington University School of Medicine and Health Sciences, Washington, DC
Get access

Summary

Clinical features and pathophysiology

Primary blepharospasm is a common adult-onset focal dystonia, characterized by involuntary contractions of the periocular muscles resulting in forceful eye closure, and impairing normal opening and closing of the eyes (Marsden,1976; Berardelli et al., 1985). The severity of blepharospasm can vary from repeated frequent blinking, causing only minor discomfort, to persistent forceful closure of the eyelids leading to functional blindness (Figure 7.1). Blepharospasm can be caused by tonic or phasic contractions of the orbicularis oculi muscles and may also be associated with levator palpebrae muscle inhibition (apraxia of eyelid opening) or involuntary movements in the lower face or jaw muscles (Meige's syndrome). In most cases blepharospasm is considered primary and is only occasionally secondary to structural brain lesions or drug induced (Jankovic, 2006).

Neurophysiological recordings of the blink reflex have given important insight into the pathophysiology of blepharospasm. In patients with blepharospasm, the recovery cycle of the R2 component of the blink reflex is enhanced, presumably owing to a lack of brain stem interneuronal inhibition (Berardelli et al., 1985, 1998). Blepharospasm is also associated with an abnormal responsiveness of the blink reflex to sensory stimuli. Recent studies with the technique of magnetic brain stimulation also suggest a loss of inhibition and increased plasticity in the central nervous system of patients with blepharospasm.

Anatomy of the periocular muscles

Knowledge of the anatomy of the upper facial muscles is essential for treating patients with blepharospasm.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albanese, A., Bentivoglio, A. R., Colosimo, C., et al. (1996). Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. J Neurol Neurosurg Psychiatry, 60, 693–4.CrossRefGoogle ScholarPubMed
Berardelli, A., Rothwell, J. C., Day, B. L. & Marsden, C. D. (1985). Pathophysiology of blepharospasm and oromandibular dystonia. Brain, 108(Pt 3), 593–608.CrossRefGoogle ScholarPubMed
Berardelli, A., Rothwell, J. C., Hallett, M., et al. (1998). The pathophysiology of primary dystonia. Brain, 121(Pt 7), 1195–212.CrossRefGoogle ScholarPubMed
Cakmur, R., Ozturk, V., Uzunel, F., Donmez, B. & Idiman, F. (2002). Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol, 249, 64–8.CrossRefGoogle ScholarPubMed
Calace, P., Cortese, G., Piscopo, R., et al. (2003). Treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Ophthalmol, 13, 331–6.CrossRefGoogle ScholarPubMed
Colosimo, C., Chianese, M., Giovannelli, M., Contarino, M. F. & Bentivoglio, A. R. (2003). Botulinum toxin type B in blepharospasm and hemifacial spasm. J Neurol Neurosurg Psychiatry, 74, 687.CrossRefGoogle ScholarPubMed
Costa, J., Espirito-Santo, C., Borges, A., et al. (2005). Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev, Jan 25(1), CD004900.Google ScholarPubMed
Jankovic, J. (2006). Treatment of dystonia. Lancet Neurol, 5, 864–72.CrossRefGoogle ScholarPubMed
Jankovic, J. & Orman, J. (1987). Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology, 37, 616–23.CrossRefGoogle ScholarPubMed
Marsden, C. D. (1976). Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?J Neurol Neurosurg Psychiatry, 39, 1204–9.CrossRefGoogle ScholarPubMed
Ward, A. B., Molenaers, G., Colosimo, C. & Berardelli, A. (2006). Clinical value of botulinum toxin in neurological indications. Eur J Neurol, 13(Suppl 4), 20–6.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×